Commentary · 6 Jan 2023
Conference abstractPublished 17 Dec 2018
Encysted papillary carcinoma
Rizgary Teaching Hospital, Iraq
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A 52 years old lady was presented with right bloody nipple discharge for 4 years. Ultrasound -RT breast-duct dilatation with irregular mass 24Ã?10 mm within the duct, mammography shoes multiple dilated linear branching density from retro areolar area to the lateral margin of RT breast with nipple retraction. Sonographic guide core biopsy was done. Microscopically finding, dilated ductal space one supported by fibrous tissue other showed prominent ductal proliferation with epitheliosismild atypical change in fibrotic stroma, patient underwent surgery by excision of entire duct from nipple to distal part about 9Ã?6Ã?3 cm axilla not touched, sent for histopathology. Microscopical Finding: Intraductal (intracystic) papillary carcinoma, no invasion is seen, all margins were clear, ER positive, PR positive and HER2 negative. She passed smooth post-operative period and received radiotherapy and now on Tamoxifen treatment. Encapsulated Papillary Carcinoma (EPC) of the breast is a rare malignancy accounting for 0.5-1% of all breast cancers, Caucasians are the most common sufferers of EPC (63%), followed by Hispanics (12-30%), Asian/Pacific Islanders (10-13%) and African-Americans (7-10.5%). EPC can be presented either as a palpable mass in an otherwise normal breast or as a swollen breast due to the presence of a huge cystic mass within it. In some cases, nipple retraction may be present with or without nipple bleeding, requiring further examination using imaging and biopsy. EPC may also be simple mammographic findings without any clinical evidence. Almost 50% of the EPCs arise in the retro-areolar region. These lesions are characterized by indolent behavior and extremely favorable prognosis. Encapsulated PC can be treated with adequate local therapy. Routine use of adjuvant therapy, particularly chemotherapy, is clearly not appropriate in view of the very low risk of subsequent events. However, hormonal therapy may be indicated in certain cases such as recurrent PC.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 25 Jan 2021
Cytohistological Concordance of Papillary Carcinoma of Thyroid and Its Variants
Case report · 26 Aug 2019
PAPILLARY CARCINOMA THYROID IN THYROGLOSSAL CYST- A CASE REPORT
Research article · 14 Dec 2015
WARTHIN TUMOR LIKE PAPILLARY CARCINOMA OF THYROID: A RARE OCCURENCE
Research article · 10 Feb 2026
Cardiac-Specific Gene TNNI3 Acts as a Potential Oncogene for Papillary Renal Cell Carcinoma
More from this journal
The newest in Journal of Women's Health Care.
Short communication · 29 Sep 2025
Advancing Women’s Health Through Cervical Cancer Screening
Short communication · 29 Sep 2025
Menopause Management: Enhancing Quality of Life for Women
Mini review · 29 Sep 2025
Breast Health: A Vital Aspect of Women’s Well-Being
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Women's Health Care
- SubjectNursing & Healthcare
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Chinar A Dzayee”

